CHM.CN Waverunner Capital Inc. CNQ 03 Apr 2026: C$0.05 after 900% jump, monitor liquidity

CHM.CN stock moved sharply today with shares at C$0.05, a 900.00% intraday increase from the prior close of C$0.01. We flag this as a high-volume mover on the CNQ exchange in Canada. Market cap sits near CAD 37,211,650.00 with 744,233,000 shares outstanding. The price spike outpaced the 50-day average (C$0.04) and the 200-day average (C$0.05). Traders should note thin liquidity and volatile microcap dynamics when assessing CHM.CN stock.

Price action and volume context for CHM.CN stock

CHM.CN stock closed at C$0.05 after a large percentage move. The reported change was C$0.0450, or 900.00%, versus the previous close. Average volume historically is 28,908.00 shares, so any active session can skew price quickly. Day range held at C$0.05 low and C$0.05 high, showing a single-price print. For market-hours traders, expect wide spreads and execution risk.

Why the move matters to traders and CHM.CN stock analysis

Microcap spikes often reflect news, corporate actions, or low float trading. Waverunner Capital Inc. (CHM.CN) completed a name change in June 2024 and holds venture investments across renewable energy and biotech. That background may attract speculative flows. We recommend checking company filings and direct statements on the company website before trading. See the company site for filings and corporate updates source.

Fundamentals and valuation snapshot for CHM.CN stock

Waverunner Capital Inc. lists in the Healthcare sector and the Drug Manufacturers – Specialty & Generic industry. Trailing metrics show EPS -0.01 and a negative P/E of -5.00. Price-to-book sits negative at -0.35, and book value per share is -0.14. Cash per share is 0.01 and free cash flow per share is -0.00. These figures point to a capital-light, early-stage profile with negative equity per share.

Technical signals, trading risks and CHM.CN stock liquidity

Price averages show a 50-day at C$0.04 and 200-day at C$0.05, placing the current print near the long-term mean. The stock has a reported shares outstanding of 744,233,000.00, which can dilute movements. Current ratio and cash coverage metrics are weak, increasing downside risk on a funded-stress event. Traders should size positions carefully and use limit orders during market hours.

Meyka AI rates CHM.CN with a score out of 100 and forecast

Meyka AI rates CHM.CN with a score out of 100: 60.89 / 100 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month median price of C$0.08 versus the current C$0.05, implying an upside of 60.00%. Forecasts are model-based projections and not guarantees.

Sector view and short-term opportunities for CHM.CN stock

Healthcare sector performance in Canada has lagged recently. The sector average one-year return is negative, and drug manufacturers face funding headwinds. Waverunner Capital’s venture exposures to renewable energy and plant-based wellness diversify risk. Short-term opportunities include event-driven trades around financing, PIPEs, or asset sales. We advise hedged exposure and confirmation of corporate announcements before adding positions.

Final Thoughts

Key takeaways on CHM.CN stock: the share price jumped to C$0.05 today, a 900.00% move on the CNQ exchange in Canada. Market cap stands at CAD 37,211,650.00 and the company reports EPS -0.01 and negative book value per share of -0.14. Meyka AI’s forecast model projects C$0.08 in 12 months, implying 60.00% upside from the current price; forecasts are model-based projections and not guarantees. Our grade, 60.89 (B, HOLD), blends benchmarks, sector context, growth metrics, and analyst signals. For active traders, the immediate focus should be liquidity, corporate filings, and any new financing that could change valuation quickly. We use Meyka AI as an AI-powered market analysis platform to surface these metrics, but investors should confirm filings and use tight risk controls in microcap trading.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.